Logo

HTG Molecular

HTG Molecular Diagnostics Q1 Revenues Drop 36 Percent

For the quarter ended March 31, the Tucson, Arizona-based firm's revenues fell to $1.4 million from $2.2 million a year ago.

HTG Molecular Preliminary Q1 Revenues Fall 56 Percent

For the three months ended March 31, the firm said that preliminary revenues for Q1 are expected to be $1.4 million compared with $3.2 million a year ago.

HTG Molecular Diagnostics FY 2020 Revenues Fall 56 Percent

For the year ended Dec. 31, 2020, the firm reported revenues of $8.5 million compared to $19.2 million in 2019, beating the Wall Street estimate of $8.3 million. 

HTG Molecular Preliminary 2020 Revenues Drop 56 Percent

The firm reported preliminary revenues of $8.5 million for full-year 2020, which would beat the consensus Wall Street estimate of $8.0 million.

HTG Molecular Completes 1-For-15 Reverse Stock Split

The company stock will now trade on a split-adjusted basis on the Nasdaq after reducing its number of shares from 200 million to 26.7 million. 

Nov 11, 2020

HTG to Expand Disease Reach With New Whole-Transcriptome Profiling Product Mid-2021
Premium

Nov 10, 2020

HTG Molecular Diagnostics Q3 Revenues Drop 67 Percent

Aug 13, 2020

BioSpyder Seeks Noninfringement Judgment in HTG Molecular Patent Dispute

Aug 12, 2020

HTG Molecular Q2 Revenues Drop 66 Percent as COVID-19 Forces Global Facility Closures

Aug 10, 2020

HTG Molecular Diagnostics, Qiagen Ink CDx Commercialization, Distribution Agreement

Jul 31, 2020

New Products Posted to GenomeWeb: Myriad Genetics, HTG Molecular Diagnostics, Twist Bioscience

Jun 26, 2020

HTG Molecular Inks $10M Secured Credit Agreement

Jun 12, 2020

HTG Molecular Signs Three European Distribution Agreements

May 13, 2020

HTG Molecular Diagnostics Q1 Revenues Drop 31 Percent Due to COVID-19 Global Facility Closures

Apr 24, 2020

People in the News: Megan Bailey, Maureen Cronin, Ronald Park, Ingo Chakravarty, More

Mar 25, 2020

HTG Molecular Diagnostics' FY 2019 Revenues Drop 11 Percent

Feb 13, 2020

Following End of Qiagen Deal, HTG Molecular to Focus on CDx Plans and Other Alliances
Premium

Jan 13, 2020

HTG Molecular Expects 11 Percent Drop in 2019 Revenues

Nov 15, 2019

HTG Molecular Diagnostics Files for $20M Stock Offering

Nov 12, 2019

HTG Molecular Diagnostics Revenues Grow 15 Percent; Firm Lowers Full-Year Guidance

Oct 11, 2019

In Brief This Week: Cardea, HTG Molecular, Novigenix, Stilla Technologies

Oct 7, 2019

HTG Molecular Warned by Nasdaq of Listing Non-Compliance

Sep 27, 2019

In Brief This Week: 10x Genomics, Yourgene, HTG Molecular, GenScript, More

Sep 19, 2019

HTG Molecular Diagnostics Prices $20M in Stock Offerings

Aug 6, 2019

HTG Molecular Q2 2019 Revenues Rise 18 Percent

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.